All stock lists
Fate Therapeutics Inc (FATE)
NASDAQ: FATE · Real-Time Price · USD
Healthcare · Biotechnology
2.06-0.04 (-2.13%)
Insider Score
––Not scored
FATE Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
FATE Stock Insider Trading Activity
FATE stock’s insider trading shows 4 sales on the open market for an estimated $306.03K by company insiders over the last 6 months.
Not enough price history.
Insider Trading Activity (Form 4 Filings)
An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.
Scored window · last 90 days0 qualifying buys0 insiders$0 bought— these are the numbers in the rankings table; the full history below shows every filing (buys, sells and older activity).
| Insider | Action | Shares | Avg Cost | Total | Δ Holdings | Held After | Date | Grade | Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| TAHL CINDY Other | Sell | 38,800 | $2.46 | $95.41K | 6.2% | 589,355 | Aug 4, 2026 | — | Form 4 |
| Valamehr Bahram CEO | Sell | 43,947 | $2.46 | $108.10K | 6.9% | 591,815 | Aug 4, 2026 | — | Form 4 |
| TAHL CINDY Other | Sell | 25,590 | $1.88 | $48.11K | 3.9% | 628,155 | May 20, 2026 | — | Form 4 |
| Valamehr Bahram CEO | Sell | 28,946 | $1.88 | $54.42K | 4.4% | 635,762 | May 20, 2026 | — | Form 4 |
| TAHL CINDY Other | Option exercise | 122,220 | $1.32 | $161.33K | 25.1% | 609,301 | May 6, 2026 | — | Form 4 |
| TAHL CINDY Other | Option exercise | 44,444 | $1.05 | $46.67K | 7.3% | 653,745 | May 6, 2026 | — | Form 4 |
| EPSTEIN ROBERT S Director | Option exercise | 25,000 | $1.69 | $42.25K | 221% | 36,331 | May 5, 2026 | — | Form 4 |
| RASTETTER WILLIAM H Director | Option exercise | 25,000 | $1.69 | $42.25K | 221% | 36,331 | May 5, 2026 | — | Form 4 |
| Green Jeremy Director | Other | 8,977,624 | — | — | 230% | 12,884,277 | Apr 20, 2026 | — | Form 4 |
| Green Jeremy Director | Other | 8,977,624 | — | — | 100% | 0 | Apr 20, 2026 | — | Form 4 |
| Adawi Kamal CFO | Award | 25,000 | — | — | 33.3% | 100,000 | Jan 15, 2026 | — | Form 4 |
| Valamehr Bahram CEO | Award | 335,000 | — | — | 102% | 664,708 | Jan 15, 2026 | — | Form 4 |
| TAHL CINDY Other | Award | 100,000 | — | — | 25.8% | 487,081 | Jan 15, 2026 | — | Form 4 |
| Valamehr Bahram CEO | Sell | 5,190 | $1.07 | $5.55K | 1.5% | 329,708 | Jan 9, 2026 | — | Form 4 |
| TAHL CINDY Other | Sell | 10,589 | $1.06 | $11.22K | 2.7% | 387,081 | Jan 9, 2026 | — | Form 4 |
| Adawi Kamal CFO | Award | 75,000 | — | — | New | 75,000 | Oct 20, 2025 | — | Form 4 |
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
- Sell (S) — Open-market or private sale
- Award (A) — Grant or award from the company, not a purchase
- Option exercise (M) — Exercise or conversion of an exempt derivative
- Other (J) — Other acquisition or disposition — the filing explains it in a footnote
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.